Cita APA

Wang, J., Han, Y., Shi, X., Li, Q., Zhang, P., Yuan, P., . . . Xu, B. (2018). Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor. Thorac Cancer.

Chicago Style Citation

Wang, Jiayu, et al. "Phase I Safety and Pharmacokinetic Study of Cipatinib, an Original Dual Tyrosine Kinase Inhibitor." Thorac Cancer 2018.

Cita MLA

Wang, Jiayu, et al. "Phase I Safety and Pharmacokinetic Study of Cipatinib, an Original Dual Tyrosine Kinase Inhibitor." Thorac Cancer 2018.